David A. Piacquad's Insider Trades & SAST Disclosures

David A. Piacquad's most recent trade in AMGEN Inc. was a trade of 6,159 Nqso (Right to Buy) done . Disclosure was reported to the exchange on April 30, 2021.

Stock Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
AMGEN Inc.
David A. Piacquad SVP, Business Development Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Apr 2021 6,159 6,159 - - Nqso (Right to Buy)
AMGEN Inc.
David A. Piacquad SVP, Business Development Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Apr 2021 709 45,146 (0%) 0% 0 Common Stock
AMGEN Inc.
David A. Piacquad SVP, Business Development Payment of exercise price or tax liability using portion of securities received from the company at price $ 239.64 per share. 30 Apr 2021 220 44,787 (0%) 0% 239.6 52,721 Common Stock
AMGEN Inc.
David A. Piacquad SVP, Business Development Payment of exercise price or tax liability using portion of securities received from the company at price $ 239.64 per share. 30 Apr 2021 139 45,007 (0%) 0% 239.6 33,310 Common Stock
AMGEN Inc.
David A. Piacquad SVP, Business Development Payment of exercise price or tax liability using portion of securities received from the company at price $ 255.52 per share. 27 Apr 2021 128 44,437 (0%) 0% 255.5 32,707 Common Stock
AMGEN Inc.
David A. Piacquad SVP, Business Development Payment of exercise price or tax liability using portion of securities received from the company at price $ 244.42 per share. 19 Mar 2021 991 44,565 (0%) 0% 244.4 242,220 Common Stock
AMGEN Inc.
David A. Piacquad SVP, Business Development Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Mar 2021 2,648 45,504 (0%) 0% 0 Common Stock
AMGEN Inc.
David A. Piacquad SVP, Business Development Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 May 2020 10,628 10,628 - - Nqso (Right to Buy)
AMGEN Inc.
David A. Piacquad SVP, Business Development Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 May 2020 1,269 42,773 (0%) 0% 0 Common Stock
AMGEN Inc.
David A. Piacquad SVP, Business Development Payment of exercise price or tax liability using portion of securities received from the company at price $ 230.98 per share. 01 May 2020 136 41,504 (0%) 0% 231.0 31,413 Common Stock
AMGEN Inc.
David A. Piacquad SVP, Business Development Payment of exercise price or tax liability using portion of securities received from the company at price $ 239.22 per share. 01 May 2020 123 41,640 (0%) 0% 239.2 29,424 Common Stock
AMGEN Inc.
David A. Piacquad SVP, Business Development Payment of exercise price or tax liability using portion of securities received from the company at price $ 236.28 per share. 27 Apr 2020 116 41,763 (0%) 0% 236.3 27,408 Common Stock
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades